⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

CNC

Centene Corporation

Healthcare · Healthcare Plans

64.06USD

-0.5200 (-0.81%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.1▲$0.05124
Next quarter$-1.09▼$-0.96513
Current year$4.89▲$3.52200
Next year$5.31▲$4.46200

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.08$2.51+1.43 (+132.6%)
2026-03-31$2.13$3.37+1.24 (+57.9%)
2025-12-31$-1.22$-1.19+0.03 (+2.5%)
2025-09-30$-0.16$0.5+0.66 (+404.3%)

Wall Street coverage

396 ratings from 40 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Argus ResearchUpgraded from HoldBuy$80Aug 11, 2026
JP MorganMaintainedNeutral$60 $67Aug 4, 2026
BernsteinMaintainedOutperform$68 $79Aug 3, 2026
BarclaysMaintainedOverweight$75 $80Jul 29, 2026
BairdMaintainedNeutral$46 $66Jul 29, 2026
TD CowenMaintainedHold$47 $65Jul 14, 2026
Truist SecuritiesMaintainedBuy$71 $78Jul 14, 2026
Wells FargoMaintainedEqual-Weight$56 $69Jul 13, 2026
RBC CapitalMaintainedSector Perform$70 $71Jul 9, 2026
Cantor FitzgeraldMaintainedOverweight$60 $75Jul 7, 2026
RBC CapitalInitiatedSector Perform$70Jun 23, 2026
MizuhoMaintainedNeutral$58 $63Jun 8, 2026
JP MorganMaintainedNeutral$52 $60Jun 8, 2026
B of A SecuritiesMaintainedBuy$72 $74Jun 4, 2026
Morgan StanleyMaintainedEqual-Weight$50 $57Jun 4, 2026
Truist SecuritiesMaintainedBuy$58 $71Jun 1, 2026
BarclaysMaintainedOverweight$63 $75May 26, 2026
UBSMaintainedNeutral$55 $61May 22, 2026
B of A SecuritiesMaintainedBuy$60 $72May 21, 2026
MizuhoMaintainedNeutral$50 $58May 20, 2026
Deutsche BankUpgraded from HoldBuy$53 $80May 20, 2026
TD CowenMaintainedHold$38 $47May 4, 2026
Wells FargoMaintainedEqual-Weight$44 $56May 1, 2026
UBSMaintainedNeutral$42 $55Apr 29, 2026
OppenheimerMaintainedOutperform$45 $58Apr 29, 2026

Insider transactions

89 filings from 18 insiders · 19 buy / 3 sell over 6m

Officers and directors of CNC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
KOSTER CHRISTOPHER A.General CounselSell56.5k$66.90$3.78MAug 26, 2026
KOSTER CHRISTOPHER A.General CounselSell47.6k$65.36$3.11MAug 18, 2026
DIAZ PAUL JDirectorGrant2.8k——Jul 28, 2026
TYLER LAUREN M.DirectorGrant3.2k——Jul 17, 2026
COUGHLIN CHRISTOPHER JDirectorGrant562——Jun 30, 2026
TYLER LAUREN M.DirectorGrant61——Jun 30, 2026
EPPINGER FREDERICK HDirectorGrant833——Jun 30, 2026
SAMUELS THEODORE R IIDirectorGrant465——Jun 30, 2026
TANJI KENNETH Y.DirectorGrant581——Jun 30, 2026
BURDICK KENNETH ADirectorSell80.0k$64.55$5.16MJun 10, 2026
DALLAS HIRAM JAMESDirectorGrant4.0k——May 12, 2026
BURDICK KENNETH ADirectorGrant4.0k——May 12, 2026
BLUME JESSICA LDirectorGrant4.0k——May 12, 2026
COUGHLIN CHRISTOPHER JDirectorGrant4.0k——May 12, 2026
FORD MONTE E.DirectorGrant4.0k——May 12, 2026
EPPINGER FREDERICK HDirectorGrant6.7k——May 12, 2026
SAMUELS THEODORE R IIDirectorGrant4.0k——May 12, 2026
TANJI KENNETH Y.DirectorGrant4.0k——May 12, 2026
COUGHLIN CHRISTOPHER JDirectorGrant1.1k——Mar 31, 2026
EPPINGER FREDERICK HDirectorGrant1.7k——Mar 31, 2026

Analyst Notes

Sign in to write

No analyst notes on CNC yet.

Analyst Ratings

18 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current271110Hold2.52
1 mo ago261210Hold2.57
2 mo ago161310Hold2.67
Price target$71.67$56.00 – $85.00
+11.9% to target